Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 131-138

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand-Based Drug Design to Propose Novel -Glucosidase Inhibitors

By  

Current Bioactive Compounds, Vol. 5, Iss. 2, 2009-06 ,pp. : 99-109

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Structure-Based and Ligand-Based Design of IKK&bgr; Inhibitors as Anti-inflammation and Anti-cancer Agents

By  

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-11 ,pp. : 3893-3917

Bentham Science Publishers

Access to resources Recommend Favorite

Ligand-Based Drug Design Methodologies in Drug Discovery Process: An Overview

By  

Current Drug Discovery Technologies, Vol. 3, Iss. 3, 2006-09 ,pp. : 155-165

Bentham Science Publishers

Access to resources Recommend Favorite

Structure and Ligand-based Design of P-glycoprotein Inhibitors: A Historical Perspective

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4197-4214

Bentham Science Publishers

Access to resources Recommend Favorite